✦ LIBER ✦

Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies

✍ Scribed by Hurwitz, H. I.; Saltz, L. B.; Van Cutsem, E.; Cassidy, J.; Wiedemann, J.; Sirzen, F.; Lyman, G. H.; Rohr, U.-P.

Book ID: 126638554
Publisher: American Society of Clinical Oncology
Year: 2011
Tongue: English
Weight: 159 KB
Volume: 29
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2010.32.3220

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

635 POSTER Arterial thromboembolic event

635 POSTER Arterial thromboembolic events in a pooled analysis of 5 randomized, controlled trials of bevacizumab with chemotherapy

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II study of combined chemotherapy

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

✍ Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, H 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 104 KB

Impact of treatment with bevacizumab bey

Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (WJOG 5910L)

✍ Masayuki Takeda, Isamu Okamoto, Takeharu Yamanaka, Kazuhiko Nakagawa, Yoichi Nak 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 149 KB

PointBreak: A Randomized Phase III Study

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer

✍ Patel, J. D.; Socinski, M. A.; Garon, E. B.; Reynolds, C. H.; Spigel, D. R.; Ols 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 243 KB

A phase II study of neoadjuvant bevacizu

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

✍ Giampietro Gasparini; Francesco Torino; Takayuki Ueno; Stefano Cascinu; Teresa T 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 305 KB

23LBA BEAM: A randomized phase II study

23LBA BEAM: A randomized phase II study evaluating the activity of BEvacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated Advanced Melanoma

✍ S.J. O'Day; K.B. Kim; J.A. Sosman; A.C. Peterson; S. Feng; D.R. Minor; J.P. Frue 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB